Kaye Evans
University of California, Irvine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kaye Evans.
Antimicrobial Agents and Chemotherapy | 2013
Jennifer S. McDanel; Courtney R. Murphy; Daniel J. Diekema; Victor Quan; Diane S. Kim; Ellena M. Peterson; Kaye Evans; Grace L. Tan; Mary K. Hayden; Susan S. Huang
ABSTRACT Chlorhexidine and mupirocin are used in health care facilities to eradicate methicillin-resistant Staphylococcus aureus (MRSA) carriage. The objective of this study was to assess the frequency of chlorhexidine and mupirocin resistance in isolates from nares carriers in multiple nursing homes and to examine characteristics associated with resistance. Nasal swab samples were collected from approximately 100 new admissions and 100 current residents in 26 nursing homes in Orange County, CA, from October 2008 to May 2011. MRSA isolates were tested for susceptibility by using broth microdilution, disk diffusion, and Etest; for genetic relatedness using pulsed-field gel electrophoresis; and for qac gene carriage by PCR. Characteristics of the nursing homes and their residents were collected from the Medicare Minimum Data Set and Long-Term Care Focus. A total of 829 MRSA isolates were obtained from swabbing 3,806 residents in 26 nursing homes. All isolates had a chlorhexidine MIC of ≤4 μg/ml. Five (0.6%) isolates harbored the qacA and/or qacB gene loci. Mupirocin resistance was identified in 101 (12%) isolates, with 78 (9%) isolates exhibiting high-level mupirocin resistance (HLMR). HLMR rates per facility ranged from 0 to 31%. None of the isolates with HLMR displayed qacA or qacB, while two isolates carried qacA and exhibited low-level mupirocin resistance. Detection of HLMR was associated with having a multidrug-resistant MRSA isolate (odds ratio [OR], 2.69; P = 0.004), a history of MRSA (OR, 2.34; P < 0.001), and dependency in activities of daily living (OR, 1.25; P = 0.004). In some facilities, HLMR was found in nearly one-third of MRSA isolates. These findings may have implications for the increasingly widespread practice of MRSA decolonization using intranasal mupirocin.
BMC Infectious Diseases | 2012
Courtney R. Murphy; Victor Quan; Diane Kim; Ellena M. Peterson; Matthew D. Whealon; Grace L. Tan; Kaye Evans; Hildy Meyers; Michele Cheung; Bruce Y. Lee; Dana B. Mukamel; Susan S. Huang
BackgroundMRSA prevalence in nursing homes often exceeds that in hospitals, but reasons for this are not well understood. We sought to measure MRSA burden in a large number of nursing homes and identify facility characteristics associated with high MRSA burden.MethodsWe performed nasal swabs of residents from 26 nursing homes to measure MRSA importation and point prevalence, and estimate transmission. Using nursing home administrative data, we identified facility characteristics associated with MRSA point prevalence and estimated transmission risk in multivariate models.ResultsWe obtained 1,649 admission and 2,111 point prevalence swabs. Mean MRSA point prevalence was 24%, significantly higher than mean MRSA admission prevalence, 16%, (paired t-test, p<0.001), with a mean estimated MRSA transmission risk of 16%.In multivariate models, higher MRSA point prevalence was associated with higher admission prevalence (p=0.005) and higher proportions of residents with indwelling devices (p=0.01). Higher estimated MRSA transmission risk was associated with higher proportions of residents with diabetes (p=0.01) and lower levels of social engagement (p=0.03).ConclusionsMRSA importation was a strong predictor of MRSA prevalence, but MRSA burden and transmission were also associated with nursing homes caring for more residents with chronic illnesses or indwelling devices. Frequent social interaction among residents appeared to be protective of MRSA transmission, suggesting that residents healthy enough to engage in group activities do not incur substantial risks of MRSA from social contact. Identifying characteristics of nursing homes at risk for high MRSA burden and transmission may allow facilities to tailor infection control policies and interventions to mitigate MRSA spread.
Infection Control and Hospital Epidemiology | 2013
Courtney R. Murphy; Lyndsey O. Hudson; Brian G. Spratt; Victor Quan; Diane Kim; Ellena M. Peterson; Grace L. Tan; Kaye Evans; Hildy Meyers; Michele Cheung; Bruce Y. Lee; Dana B. Mukamel; Mark C. Enright; Matthew D. Whealon; Susan S. Huang
We assessed characteristics associated with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) carriage among residents of 22 nursing homes. Of MRSA-positive swabs, 25% (208/824) were positive for CA-MRSA. Median facility CA-MRSA percentage was 22% (range, 0%-44%). In multivariate models, carriage was associated with age less than 65 years (odds ratio, 1.2; P<.001) and Hispanic ethnicity (odds ratio, 1.2; P=.006). Interventions are needed to target CA-MRSA.
Journal of Clinical Microbiology | 2012
Trang Nguyen; Kaye Evans; Rosalinda A. Goh; Grace L. Tan; Ellena M. Peterson
ABSTRACT Campylobacter (Campy; BD Diagnostics, Sparks, MD), Spectra VRE (Remel, Lenexa, KS), and bile-esculin-azide-vancomycin (BEAV; Remel) agars were compared for their ability to detect vancomycin-resistant enterococci (VRE) in 750 stool specimens. The media were compared at 24 h and 48 h of incubation at 35°C and 42°C. When incubated for 24 h at 35°C, Campy was the most sensitive (97.8%) and specific (99.9%) but was comparable to Spectra, which has a sensitivity of 95.6% and a specificity of 99.1%, whereas BEAV was significantly less sensitive (90%) and specific (96.1%). Incubation at 42°C or extended incubation at 35°C for 48 h yielded no advantage over incubation at 35°C for 24 h.
Journal of Clinical Microbiology | 1992
Kaye Evans; Audrey Nakasone; P A Sutherland; L M de la Maza; E M Peterson
Infection Control and Hospital Epidemiology | 2016
James A. McKinnell; Loren G. Miller; Raveena Singh; Ken Kleinman; Ellena M. Peterson; Kaye Evans; Tabitha Dutciuc; Lauren Heim; Adrijana Gombosev; Marlene Estevez; Bryn Launer; Tom Tjoa; Steven Tam; Michael Bolaris; Susan S. Huang
American Journal of Clinical Pathology | 1986
Ellena M. Peterson; Kaye Evans; Janet T. Shigei; Marie Pezzlo; Luis M. de la Maza
Open Forum Infectious Diseases | 2016
Loren G. Miller; James A. McKinnell; Raveena Singh; Ken Kleinman; Adrijana Gombosev; Tabitha Dutciuc; Kaye Evans; Thomas Tjoa; Lauren Heim; Bryn Launer; Michael Bolaris; Kyle Ramsay; Diane Kim; Marlene Estevez; Ellena M. Peterson; Susan S. Huang
Journal of Clinical Microbiology | 1986
Kaye Evans; E M Peterson; J I Curry; J R Greenwood; L M de la Maza
Open Forum Infectious Diseases | 2017
Raveena Singh; John A. Jernigan; Rachel B. Slayton; Nimalie D. Stone; James A. McKinnell; Loren G. Miller; Ken Kleinman; Lauren Heim; Tabitha Dutciuc; Marlene Estevez; Gabrielle Gussin; Justin Chang; Ellena M. Peterson; Kaye Evans; Bruce Y. Lee; Leslie E. Mueller; Sarah M. Bartsch; Matthew Zahn; Lynn Janssen; Robert A. Weinstein; Mary K. Hayden; Shruti K. Gohil; Steven T. Park; Steven Tam; Raheeb Saavedra; Stacey Yamaguchi; Harold Custodio; Jenny Nguyen; Thomas Tjoa; Jiayi He